Data gathered: May 30
AI Stock Analysis - Forte Biosciences (FBRX)
Analysis generated March 25, 2025. Powered by Chat GPT.
Forte Biosciences is a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for the treatment of dermatological diseases. The company's primary focus is on developing treatments that address critical unmet medical needs in dermatology, driven by a robust pipeline and strategic partnerships. This dedication to specialized therapeutic areas makes Forte Biosciences a potential player in the niche but essential biopharma sector.
Stock Alerts - Forte Biosciences (FBRX)
 |
Forte Biosciences | May 29 Price is down by -12.2% in the last 24h. |
|
Forte Biosciences | May 28 Price is up by 8.2% in the last 24h. |
|
Forte Biosciences | May 27 Price is up by 10.1% in the last 24h. |
|
Forte Biosciences | May 23 Price is up by 7.6% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Forte Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,045 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Forte Biosciences
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
| Price | $8.76 |
| Target Price | Sign up |
| Volume | 11,440 |
| Market Cap | $64M |
| Year Range | $4.18 - $28 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX)May 29 - ETF Daily News |
Forte Biosciences Q1 Operating Expenses USD 16.124 MillionMay 15 - Finnhub |
|
Forte Biosciences, Inc. Announces Results and Provides UpdateMay 15 - Finnhub |
|
 |
Financial Comparison: OPKO Health (NASDAQ:OPK) and Forte Biosciences (NASDAQ:FBRX)May 14 - ETF Daily News |
|
Forte Biosciences (FBRX) Projected to Post Quarterly Earnings on MondayMay 10 - ETF Daily News |
|
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX)May 1 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -16M | -16M | -1.119 |
| Q4 '24 | 0 | 0 | 0 | -7.2M | -7.3M | 0.000 |
| Q3 '24 | 0 | 0 | 0 | -8.4M | -8.6M | -4.540 |
| Q2 '24 | 0 | 10,000 | -10,000 | -13M | -13M | -0.270 |
| Q1 '24 | 6,000 | 9,000 | -9,000 | -7.4M | -7.8M | -0.160 |
Insider Transactions View All
| Riley Antony A filed to buy 30,776 shares at $5.6. November 22 '24 |
| Wagner Paul A. filed to buy 1,823,236 shares at $0.8. December 20 '23 |
| Wagner Paul A. filed to buy 1,813,236 shares at $0.7. December 15 '23 |
| Wagner Paul A. filed to buy 1,803,236 shares at $0.7. December 15 '23 |
| Wagner Paul A. filed to buy 1,792,716 shares at $0.6. December 12 '23 |
Similar companies
Read more about Forte Biosciences (FBRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Forte Biosciences?
The Market Cap of Forte Biosciences is $64M.
What is the current stock price of Forte Biosciences?
Currently, the price of one share of Forte Biosciences stock is $8.76.
How can I analyze the FBRX stock price chart for investment decisions?
The FBRX stock price chart above provides a comprehensive visual representation of Forte Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Forte Biosciences shares. Our platform offers an up-to-date FBRX stock price chart, along with technical data analysis and alternative data insights.
Does FBRX offer dividends to its shareholders?
As of our latest update, Forte Biosciences (FBRX) does not offer dividends to its shareholders. Investors interested in Forte Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Forte Biosciences?
Some of the similar stocks of Forte Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.